Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The European HBV Registry: A Joint Initiative of TherVacB and DZIF

NCT05051098 is registered in ClinicalTrials.gov with Hannover Medical School as lead sponsor.

NCT NCT05051098
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05051098 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The European HBV Registry: A Joint Initiative of TherVacB and DZIF
Lead sponsor
Hannover Medical School
Phase
Observational
Overall status
Recruiting
Start date
May 6, 2021
Completion date
December 31, 2031
Enrollment
3,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis b virus infection